Answers are grounded in this paper and cite their sources.
Acute kidney injury (AKI) is a common and heterogeneous clinical syndrome characterised by a rapid decline in renal function and caused by a range of insults, including ischaemia‑reperfusion injury, sepsis, nephrotoxic drugs, hypovolaemia, major surgery and transplantation‑related injury. AKI is prone to progression to chronic kidney disease (CKD), and no effective treatment is currently available. Pyruvate dehydrogenase kinase 4 (PDK4), a regulator of mitochondrial metabolism, phosphorylates the E1α subunit of the pyruvate dehydrogenase (PDH) complex, thereby suppressing PDH enzymatic activity and limiting pyruvate oxidation. In renal tubular epithelial cells and other renal cell types, increased PDK4 mRNA expression and/or PDK4 protein abundance has been associated with enhanced inhibitory signalling through the PDK4‑PDH complex axis, typically reflected by increased phosphorylation of the PDH E1α subunit, reduced total PDH complex activity and suppressed mitochondrial pyruvate oxidation. These changes contribute to metabolic reprogramming, mitochondrial dysfunction, oxidative stress, inflammatory activation and cell death. Accumulating evidence suggests that PDK4‑mediated metabolic dysregulation contributes to tubular injury and maladaptive repair during AKI and the AKI‑to‑CKD transition, although its effects remain dependent on disease context and biological stage. The present review summarises the molecular regulation of PDK4, its pathological relevance in experimental AKI and the potential implications of PDK4 for therapeutic intervention and biomarker development. Moreover, the limited evidence supporting PDK4 as a candidate biomarker in AKI and the AKI‑to‑CKD transition is discussed. Although PDK4 protein is biologically linked to tubular metabolic stress and renal injury, its clinical biomarker performance has not yet been validated and further studies are required to determine its diagnostic and prognostic utility.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: